Merck said it would seek emergency authorization from the Food and Drug Administration for its drug, known as molnupiravir, as soon as possible. The pills could be available by late this year.
Dr. Fauci pointed to the stark difference in how many people died during Merck’s clinical trial for the treatment, with eight among the placebo group and none among those taking the drug. “That’s very impressive, so we really look forward to the implementation of this and to its effect on people who are infected,” he said.
The federal government has placed advanced orders for 1.7 million doses of the new medication. But Dr. Scott Gottlieb, the former F.D.A. commissioner under President Trump and a board member for Pfizer, said that amount was “not enough” on CBS’ Face the Nation, covering only one month’s worth of infections in Southern states since the Delta variant emerged. He also contrasted that quantity with the national stockpile of medication to treat a flu pandemic, which he said numbers in the tens of millions.
Earlier, Dr. Fauci dismissed the notion that federal officials had not procured enough of the medicine, saying they had placed “a good bet” on the treatment.
“We have options for millions more,” he said on the program, predicting the company would ramp up production to meet demand in the United States and across the world.
Source Article from https://www.nytimes.com/2021/10/03/health/merck-covid-pill-vaccine-fauci.html
Comments